v3.25.4
SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS (Details) - USD ($)
6 Months Ended 12 Months Ended
Dec. 31, 2025
Jun. 30, 2025
Impairment Effects on Earnings Per Share [Line Items]    
Cash and Cash Equivalents $ 3,342,713 $ 6,832,725
Cash [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 157,991 130,288
Unrealized Gain (Loss)
Fair Value
Cash and Cash Equivalents 157,991 130,288
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 3,184,722 6,702,437
Unrealized Gain (Loss)
Fair Value 3,184,722 6,702,437
Cash and Cash Equivalents 3,184,722 6,702,437
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 3,342,713 6,832,725
Unrealized Gain (Loss)
Fair Value 3,184,722 6,702,437
Cash and Cash Equivalents $ 3,342,713 $ 6,832,725